EGFR and neoplasm: In breast cancer, nuclear-localized USP43 binds to the NuRD complex and exerts tumor-suppressive effects by deubiquitinating H2BK120 and suppressing the transcription of EGFR, whereas cytoplasmic retention of USP43 contributes to tumor progression [20].